← Evidence map

ArticleBiometrics2020

Bayesian design of biosimilars clinical programs involving multiple therapeutic indications.

Matthew A Psioda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2020
2021
2022
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 31631321